""

about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

department of Medicine

Section of pulmonary and critical care medicine

Research

 

Physicians at the Temple Lung Center are continuously investigating new approaches to common and serious diseases.  Many patients benefit from access to new drugs or procedures made possible by our major role in pulmonary clinical trials.  For more information, call 215-707-1359 or e-mail us at breathe@temple.edu.

Current Clinical Trials:

 

Idiopathic Pulmonary Fibrosis State Registry

 

EMPHYSEMA & COPD SUFFERERS:

Antibiotic therapy may help


The National Institutes of Health is sponsoring a study to determine whether antibiotic therapy can reduce the number and severity of chronic obstructive pulmonary disease (COPD) flare-ups. Only 1,130 patients nationwide will be selected to participate in this reseach study.

 

To participate you must:

  • Be 40 years old or older
  • Have moderate-to-severe COPD
  • Be a smoker or ex-smoker
  • Participates receive the highest level of care and up to $450.

To see if you qualify, please call 215-707-1359 and refer to study #4.

 


COPD SUFFERERS:

Do you cough or have shortness of breath?

The Temple Lung Center is conducting a clinical research study to test a new medication that may help patients with COPD to breathe easier.

 

You may qualify if you are:

  • 44 years old or older
  • Have moderate to severe COPD
  • Have not smoked for at least one year
  • Participants receive the study-related care and up to $1,025 for 15 visits over 2-1/2 years, and may have a chance to receive a new investigational drug.
  • To see if you qualify, please call 215-707-1359 and refer to study #25.

COPD SUFFERERS:

 

The National Institutes of Health is sponsoring a study to compare two FDA-approved vaccines for pneumonia.

 

You may qualify if you are:

  • 40 years old or older
  • A smoker or ex-smoker
  • Have moderate-to-severe COPD


Participants receive vaccine (at no cost) and up to $200 for completion of all study visits (4 clinic visits and 5 phone contacts) over 24 months.

 

To see if you qualify, please call 215-707-1359.